CAR-T Cell Therapy Moves Beyond Cancer to Autoimmune Diseases

CAR-T cell therapy, approved for some blood cancers, is being studied for lupus, MS, and scleroderma. Yale Medicine experts explain how it works, its risks, and who may qualify.